State of Alaska Department of Revenue Buys 7,135 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

State of Alaska Department of Revenue raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 117,851 shares of the healthcare conglomerate’s stock after acquiring an additional 7,135 shares during the quarter. UnitedHealth Group makes up about 0.7% of State of Alaska Department of Revenue’s portfolio, making the stock its 15th biggest position. State of Alaska Department of Revenue’s holdings in UnitedHealth Group were worth $68,904,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also bought and sold shares of UNH. Trilogy Capital Inc. purchased a new position in shares of UnitedHealth Group during the 1st quarter valued at about $233,000. Diversified Trust Co raised its stake in shares of UnitedHealth Group by 2.3% during the 1st quarter. Diversified Trust Co now owns 44,775 shares of the healthcare conglomerate’s stock valued at $22,151,000 after buying an additional 1,021 shares during the last quarter. BKM Wealth Management LLC increased its stake in shares of UnitedHealth Group by 34.7% in the 1st quarter. BKM Wealth Management LLC now owns 5,157 shares of the healthcare conglomerate’s stock valued at $2,551,000 after purchasing an additional 1,328 shares in the last quarter. Horizon Wealth Management LLC increased its stake in shares of UnitedHealth Group by 4.5% in the 1st quarter. Horizon Wealth Management LLC now owns 1,177 shares of the healthcare conglomerate’s stock valued at $582,000 after purchasing an additional 51 shares in the last quarter. Finally, Little House Capital LLC increased its stake in shares of UnitedHealth Group by 33.2% in the 1st quarter. Little House Capital LLC now owns 11,595 shares of the healthcare conglomerate’s stock valued at $5,736,000 after purchasing an additional 2,888 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.7 %

Shares of NYSE UNH opened at $564.56 on Monday. The firm has a market cap of $521.33 billion, a price-to-earnings ratio of 36.78, a PEG ratio of 1.66 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $608.63. The business’s 50 day moving average is $583.52 and its two-hundred day moving average is $538.58.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.56 earnings per share. Research analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analyst Ratings Changes

Several equities analysts recently weighed in on UNH shares. Morgan Stanley cut their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Barclays lowered their price objective on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Robert W. Baird lifted their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. KeyCorp assumed coverage on UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. Finally, HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.